A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

H8H-MC-LAHX -

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine.

Trial Summary

Age Range
6 - 17 years
Conditions the trial is for
Migraines
What the trial is testing?
Lasmiditan
Could I receive a Placebo?
No
Enrollment Goal
18
Trial Dates
Jul 22, 2019 - Feb 24, 2020
How long will I be in the trial?
The study will last about 6 weeks, and includes 4 visits.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.